Michael Tetzlaff, MD, PhD
SESSIONS
S021 Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines
Mar 8, 2024
•
1:00 PM - 12:00 AM
•
Room 28D
DISCLOSURES
Merck – Other(Fees); Philogen S.p.A. – Advisory Board(Fees); Regeneron – Advisory Board(Honoraria);